Release of internal reports could therefore be an important and potentially almost immediately achievable first step toward increasing transparency of trials.
Various private (Green et al., 2015; Peart, 2015) and public initiatives (Collins and Tabak, 2014) have been established to increase the transparency of trials and the release of data: however, given the volume of data that is not captured and the incentives for companies not to disclose certain data, these efforts are not enough.
This study uniquely analyses the transparency of clinical trial information for new drugs, whereas other studies analyse transparency on the trial level.
39 The objective of the statement is to enable readers to critically appraise and interpret trials by providing authors with guidance about how to improve the clarity, accuracy, and transparency of their trial reports.
The lack of transparency of clinical trial information on this drug to the wider research community is preventing proper discussion of this issue among professionals.
Some liberal legal scholars, though, have praised the relative transparency of the trial, because party leaders unexpectedly allowed many of the edited court transcripts to be posted on a running court microblog even if crucial testimony that implicated other leaders was kept secret.
This is a first step towards increasing the transparency of the trial funding sources.
The strength of the study is that we openly report recruitment challenges and strategies to provide methodological transparency of this trial to other researchers.
The EU Clinical Trial Regulation, which was implemented in June 2014, but will not come fully into force until May 2016, could become a milestone with respect to transparency of clinical trial data and results [ 61, 94, 95].
Notably, the All Trials movement pushing for transparency of pharmaceutical trials has garnered much attention from the public and press over recent months.
